The interaction between tobacco exposure and HPV infection in the context of OPSCC has significant implications for standard of care treatment regimens.
How Safe are E-Cigarettes?
Otolaryngolgists weigh in on FDA proposal to regulate alternative tobacco products
Otolaryngologists Manipulated by Tobacco Industry
How did the tobacco industry enlist otolaryngologists in support of efforts to reassure consumers that cigarettes were safe?
HPV-Positive Oropharnygeal Cancer Has Better Prognosis than Tobacco-Induced Cancer
Mounting evidence suggests that human papillomavirus (HPV)-positive oropharyngeal cancer has an improved prognosis compared with HPV-negative disease. The most recent supportive evidence comes from an analysis of a Phase III trial presented at the 2009 annual meeting of the American Society of Clinical Oncology.